Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2021 | 08-2020 | 08-2019 | 08-2018 | 08-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,794 | 60,713 | 30,181 | 35,948 | 39,776 |
| Receivables | 594,147 | 544,429 | 657,932 | 654,661 | 681,620 |
| Inventories | 352,949 | 368,180 | 413,258 | 395,219 | 399,344 |
| Other current assets | 3,868 | 0 | 0 | 0 | 0 |
| TOTAL | $989,758 | $973,322 | $1,101,371 | $1,085,828 | $1,120,740 |
| Non-Current Assets | |||||
| PPE Net | 230,824 | 234,896 | 107,130 | 101,015 | 95,280 |
| Investments And Advances | 2,400 | 1,200 | 87,849 | N/A | N/A |
| Intangibles | 255,270 | 268,117 | 280,271 | 265,718 | 193,659 |
| Other Non-Current Assets | 51,690 | 65,436 | 88,593 | 50,195 | 41,397 |
| TOTAL | $540,184 | $569,649 | $563,843 | $416,928 | $330,336 |
| Total Assets | $1,529,942 | $1,542,971 | $1,665,214 | $1,502,756 | $1,451,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,866 | 8,260 | 59,310 | 1,972 | 1,608 |
| Accounts payable and accrued liabilities | 719,581 | 707,725 | 790,270 | 774,920 | 751,500 |
| TOTAL | $825,475 | $832,682 | $887,481 | $814,591 | $851,033 |
| Non-Current Liabilities | |||||
| Long Term Debt | 117,874 | 70,423 | 169,453 | 88,513 | 28,642 |
| Other Non-Current Liabilities | 15,419 | 36,481 | 82,351 | 117,051 | 15,599 |
| TOTAL | $263,963 | $252,543 | $255,425 | $192,969 | $45,797 |
| Total Liabilities | $1,089,438 | $1,085,225 | $1,142,906 | $1,007,560 | $896,830 |
| Shareholders' Equity | |||||
| Common Shares | 566,461 | 566,461 | 566,461 | 566,461 | 566,461 |
| Retained earnings | -154,065 | -151,090 | -110,189 | -104,664 | -104,664 |
| Other shareholders' equity | 26,414 | 38,526 | 62,645 | 46,987 | 92,449 |
| TOTAL | $438,810 | $453,897 | $518,917 | $508,784 | $554,246 |
| Total Liabilities And Equity | $1,528,248 | $1,539,122 | $1,661,823 | $1,516,344 | $1,451,076 |